欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
FR/H/6215/002
药品名称
Glucovance HR-H-253928915 HR Glucovance 6742/2014/01-02-03-04-05 RO Glucovance H/03/00705/003-004 SI
活性成分
glibenclamide 5.0 mg
metformin hydrochloride 500.0 mg
剂型
Film-coated tablet
上市许可持有人
Dummy PR created for all purely national authorised products included in the WS procedure MA: Merck Sante
参考成员国 - 产品名称
France (FR)
互认成员国 - 产品名称
Romania (RO)
Slovenia (SI)
Croatia (HR)
许可日期
2021/05/31
最近更新日期
2024/06/21
药物ATC编码
A10BD02 metformin and sulfonylureas
申请类型
TypeLevel1：
[not specified]
TypeLevel2：
[not specified]
TypeLevel3：
[not specified]
TypeLevel4：
[not specified]
TypeLevel5：
[not specified]
附件文件下载
Final Product Information
|
_Combined_EN_GIR FR_H_181_002 II WS245 2022Mar11 Clean__Combined_EN_GIR FR_H_181_002 II WS245 2022Mar11 Clean
Date of last change:2024/09/06
Final Product Information
|
_Combined_EN_GIR FR_H_181_003 II WS245 2022Mar11 Clean__Combined_EN_GIR FR_H_181_003 II WS245 2022Mar11 Clean
Date of last change:2024/09/06
Final Product Information
|
_Combined_EN_GLV FR_H_200_003 II WS245 2022Mar11 Clean__Combined_EN_GLV FR_H_200_003 II WS245 2022Mar11 Clean
Date of last change:2024/09/06
Final Product Information
|
Combined_EN_GIR FR_H_181_001 II WS245 2022Mar11 Clean__Combined_EN_GIR FR_H_181_001 II WS245 2022Mar11 Clean
Date of last change:2024/09/06
Final Product Information
|
Combined_EN_GLV FR_H_200_001 II WS245 2022Mar11 Clean__Combined_EN_GLV FR_H_200_001 II WS245 2022Mar11 Clean
Date of last change:2024/09/06
Final Product Information
|
Combined_EN_GLV FR_H_200_002 II WS245 2022Mar11 Clean__Combined_EN_GLV FR_H_200_002 II WS245 2022Mar11 Clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase